Novavax (NVAX) Total Current Liabilities (2010 - 2026)
Novavax (NVAX) reported Total Current Liabilities of $330.57 million for Q2 2026, down 15.0% from $389.14 million a year earlier and down 3.5% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Total Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax posted Total Current Liabilities of $459.95 million, down 60.2% from FY2024.
- Total Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- By year, Total Current Liabilities came in at $1.15 billion in FY2024 (-29.4%), $1.64 billion in FY2023 (-33.5%), $2.46 billion in FY2022 (+2.9%) and $2.39 billion in FY2021 (+312.4%).
- The Q2 2026 figure ranks as the lowest quarterly Total Current Liabilities since Q3 2020.
- Year over year, Total Current Liabilities has now declined in each of the last 14 quarters, with an average decline of 40.1% over the last eight quarters.
- The high point for year-over-year Total Current Liabilities in five years was Q3 2021 (growth of 633.0%); the low point was Q2 2025 (a decline of 66.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $342.46 million (Q1 2026), $459.95 million (Q4 2025) and $429.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 330.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 330.57 Mn |
| Mar 31, 2026 | 342.46 Mn |
| Dec 31, 2025 | 459.95 Mn |
| Sep 30, 2025 | 429.87 Mn |
| Jun 30, 2025 | 389.14 Mn |
| Mar 31, 2025 | 422.17 Mn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 804.38 Mn |
| Dec 31, 2023 | 1.64 Bn |
| Sep 30, 2023 | 1.47 Bn |
| Jun 30, 2023 | 1.60 Bn |
| Mar 31, 2023 | 1.92 Bn |
| Dec 31, 2022 | 2.46 Bn |
| Sep 30, 2022 | 1.67 Bn |
| Jun 30, 2022 | 2.16 Bn |
| Mar 31, 2022 | 2.26 Bn |
| Dec 31, 2021 | 2.39 Bn |
| Sep 30, 2021 | 1.75 Bn |
API Access
Novavax Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();